相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation
Dingyuan Luo et al.
CARCINOGENESIS (2019)
MTOR inhibitor-based combination therapies for pancreatic cancer
Zonera Hassan et al.
BRITISH JOURNAL OF CANCER (2018)
Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42
Gina L. Razidlo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras
Naveen A. Mallangada et al.
MOLECULAR CARCINOGENESIS (2018)
Role of Epithelial-Mesenchymal Transition in Tumor Progression
N. A. Gloushankova et al.
BIOCHEMISTRY-MOSCOW (2018)
Downregulation of STAT3/NF-B potentiates gemcitabine activity in pancreatic cancer cells
Jingjing Gong et al.
MOLECULAR CARCINOGENESIS (2017)
A central role for cadherin signaling in cancer
Antonis Kourtidis et al.
EXPERIMENTAL CELL RESEARCH (2017)
Chemoresistance in pancreatic cancer: Emerging concepts
Manu Gnanamony et al.
ONCOLOGY LETTERS (2017)
Gemcitabine treatment promotes pancreatic cancer sternness through the Nox/ROS/NF-κB/STAT3 signaling cascade
Zhengle Zhang et al.
CANCER LETTERS (2016)
Mitochondrial Stat3, the Need for Design Thinking
Rui Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
GEMMs as preclinical models for testing pancreatic cancer therapies
Aarthi Gopinathan et al.
DISEASE MODELS & MECHANISMS (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer
Kolaparthi Venkatasubbarao et al.
MOLECULAR CANCER (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice
Gerardo G. Mackenzie et al.
PLOS ONE (2013)
The MEK-ERK Pathway Is Necessary for Serine Phosphorylation of Mitochondrial STAT3 and Ras-Mediated Transformation
Daniel J. Gough et al.
PLOS ONE (2013)
A Novel Ras Inhibitor (MDC-1016) Reduces Human Pancreatic Tumor Growth in Mice
Gerardo G. Mackenzie et al.
NEOPLASIA (2013)
EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
Carolina Navas et al.
CANCER CELL (2012)
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Christine M. Ardito et al.
CANCER CELL (2012)
Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?
Jie-Er Ying et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
Akihisa Fukuda et al.
CANCER CELL (2011)
Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
Marina Lesina et al.
CANCER CELL (2011)
Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
Gerardo G. Mackenzie et al.
CANCER PREVENTION RESEARCH (2011)
Chemotherapeutic Properties of Phospho-Nonsteroidal Anti-Inflammatory Drugs, a New Class of Anticancer Compounds
Liqun Huang et al.
CANCER RESEARCH (2011)
STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis
Ryan B. Corcoran et al.
CANCER RESEARCH (2011)
The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro
C. Huang et al.
NEOPLASMA (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Phospho-Sulindac (OXT-328), a Novel Sulindac Derivative, Is Safe and Effective in Colon Cancer Prevention in Mice
Gerardo G. Mackenzie et al.
GASTROENTEROLOGY (2010)
Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship?
Bharat B. Aggarwal et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect
Wenping Zhao et al.
CARCINOGENESIS (2009)
Biomarkers for epithelial-mesenchymal transitions
Michael Zeisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-κB and STAT3 pathways in Hodgkin's lymphoma cells
Gerardo G. Mackenzie et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Src continues aging: Current and future clinical directions
Scott Kopetz et al.
CLINICAL CANCER RESEARCH (2007)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)